A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity

Cellular Immunology

Volumn 251, Issue 1, 2008, Pages 50-55

  Lee, Kyoo A ^a   Kang, Min Hee ^a   Lee, Yoon Sook ^a   Kim, Yeon Jeong ^a   Kim, Dong Hyeon ^a   Ko, Hyun Jeong ^a   Kang, Chang Yuil ^a  

^a Tumor Microenvironment Global Core Research Center   (South Korea)

Author keywords

Galactosylceramide; Airway inflammation; Interleukin 17; Natural killer T cell; NKT cell

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4;

ARTICLE; BRONCHUS HYPERREACTIVITY; CELL ACTIVATION; CELL INFILTRATION; CELL POPULATION; CYTOKINE PRODUCTION; ENZYME ACTIVATION; FEMALE; IMMUNE SYSTEM; INFLAMMATION; MOUSE; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE; FEMALE; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; INTERLEUKIN-17; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; NEUTROPHILS; RECEPTORS, ANTIGEN, T-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; T-LYMPHOCYTE SUBSETS;

ANIMALIA;

EID: 44549084970     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2008.03.004     Document Type: Article

References (33)

1. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23 (2005) 877-900
2. Bendelac A., Savage P.B., and Teyton L. The biology of NKT cells. Annu. Rev. Immunol. 25 (2007) 297-336
3. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., and Taniguchi M. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278 (1997) 1626-1629
4. Chackerian A., Alt J., Perera V., and Behar S.M. Activation of NKT cells protects mice from tuberculosis. Infect. Immun. 70 (2002) 6302-6309
5. Smyth M.J., Crowe N.Y., Pellicci D.G., Kyparissoudis K., Kelly J.M., Takeda K., Yagita H., and Godfrey D.I. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 99 (2002) 1259-1266
6. Gonzalez-Aseguinolaza G., Van Kaer L., Bergmann C.C., Wilson J.M., Schmieg J., Kronenberg M., Nakayama T., Taniguchi M., Koezuka Y., and Tsuji M. Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 195 (2002) 617-624
7. Sharif S., Arreaza G.A., Zucker P., Mi Q.S., Sondhi J., Naidenko O.V., Kronenberg M., Koezuka Y., Delovitch T.L., Gombert J.M., Leite-De-Moraes M., Gouarin C., Zhu R., Hameg A., Nakayama T., Taniguchi M., Lepault F., Lehuen A., Bach J.F., and Herbelin A. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 7 (2001) 1057-1062
8. Singh A.K., Wilson M.T., Hong S., Olivares-Villagomez D., Du C., Stanic A.K., Joyce S., Sriram S., Koezuka Y., and Van Kaer L. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194 (2001) 1801-1811
9. Gonzalez-Aseguinolaza G., de Oliveira C., Tomaska M., Hong S., Bruna-Romero O., Nakayama T., Taniguchi M., Bendelac A., Van Kaer L., Koezuka Y., and Tsuji M. alpha-galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA 97 (2000) 8461-8466
10. Crowe N.Y., Coquet J.M., Berzins S.P., Kyparissoudis K., Keating R., Pellicci D.G., Hayakawa Y., Godfrey D.I., and Smyth M.J. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202 (2005) 1279-1288
11. Terabe M., Swann J., Ambrosino E., Sinha P., Takaku S., Hayakawa Y., Godfrey D.I., Ostrand-Rosenberg S., Smyth M.J., and Berzofsky J.A. A nonclassical non-V alpha 14J alpha 18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J. Exp. Med. 202 (2005) 1627-1633
12. Godfrey D.I., and Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114 (2004) 1379-1388
13. Kolls J.K., and Linden A. Interleukin-17 family members and inflammation. Immunity 21 (2004) 467-476
14. Khader S.A., Bell G.K., Pearl J.E., Fountain J.J., Rangel-Moreno J., Cilley G.E., Shen F., Eaton S.M., Gaffen S.L., Swain S.L., Locksley R.M., Haynes L., Randall T.D., and Cooper A.M. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8 (2007) 369-377
15. Lockhart E., Green A.M., and Flynn J.L. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177 (2006) 4662-4669
16. Kikly K., Liu L., Na S.Q., and Sedgwick J.D. The IL-23/Th(17)axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 18 (2006) 670-675
17. Stark M.A., Huo Y., Burcin T.L., Morris M.A., Olson T.S., and Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22 (2005) 285-294
18. Michel M.L., Keller A.C., Paget C., Fujio M., Trottein F., Savage P.B., Wong C.H., Schneider E., Dy M., and Leite-de-Moraes M.C. Identification of an IL-17-producing NK1.1neg iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204 (2007) 995-1001
19. Takikawa H., Muto S.E., and Mori K. Synthesis of sphingosine relatives, part 20. Diastereoselective epoxidation of the double bond at C-4 of sphingosines to provide phytosphingosine relatives such as alpha-galactosylceramide KRN7000. Tetrahedron 54 (1998) 3141-3150
20. Hamelmann E., Schwarze J., Takeda K., Oshiba A., Larsen G.L., Irvin C.G., and Gelfand E.W. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156 (1997) 766-775
21. Chung Y., Cho J., Chang Y.S., Cho S.H., and Kang C.Y. Preventive and therapeutic effects of oral tolerance in a murine model of asthma. Immunobiology 206 (2002) 408-423
22. Parekh V.V., Wilson M.T., Olivares-Villagomez D., Singh A.K., Wu L., Wang C.R., Joyce S., and Van Kaer L. Glycolipid antigen induces long-term natural killer T cell anergy in mice. J. Clin. Invest. 115 (2005) 2572-2583
23. Meyer E.H., Goya S., Akbari O., Berry G.J., Savage P.B., Kronenberg M., Nakayama T., DeKruyff R.H., and Umetsu D.T. Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc. Natl. Acad. Sci. USA 103 (2006) 2782-2787
24. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., Pin J.J., Garrone P., Garcia E., Saeland S., Blanchard D., Gaillard C., Das Mahapatra B., Rouvier E., Golstein P., Banchereau J., and Lebecque S. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183 (1996) 2593-2603
25. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., and Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6 (2005) 1133-1141
26. Benlagha K., Kyin T., Beavis A., Teyton L., and Bendelac A. A thymic precursor to the NK T cell lineage. Science 296 (2002) 553-555
27. McNab F.W., Pellicci D.G., Field K., Besra G., Smyth M.J., Godfrey D.I., and Berzins S.P. Peripheral NK1.1 NKT cells are mature and functionally distinct from their thymic counterparts. J. Immunol. 179 (2007) 6630-6637
28. Lisbonne M., Diem S., de Castro Keller A., Lefort J., Araujo L.M., Hachem P., Fourneau J.M., Sidobre S., Kronenberg M., Taniguchi M., Van Endert P., Dy M., Askenase P., Russo M., Vargaftig B.B., Herbelin A., and Leite-de-Moraes M.C. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171 (2003) 1637-1641
29. Akbari O., Stock P., Meyer E., Kronenberg M., Sidobre S., Nakayama T., Taniguchi M., Grusby M.J., DeKruyff R.H., and Umetsu D.T. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9 (2003) 582-588
30. Kim J.O., Kim D.H., Chang W.S., Hong C., Park S.H., Kim S., and Kang C.Y. Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model. J. Allergy Clin. Immunol. 114 (2004) 1332-1338
31. Barczyk A., Pierzchala W., and Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med. 97 (2003) 726-733
32. Schnyder-Candrian S., Togbe D., Couillin I., Mercier I., Brombacher F., Quesniaux V., Fossiez F., Ryffel B., and Schnyder B. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203 (2006) 2715-2725
33. Kim D.H., Chang W.S., Lee Y.S., Lee K.A., Kim Y.K., Kwon B.S., and Kang C.Y. 4-1BB engagement costimulates NKT cell activation and exacerbates NKT cell ligand-induced airway hyperresponsiveness and inflammation. J. Immunol. 180 (2008) 2062-2068